Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: Preliminary study

Radiology

Volumn 239, Issue 3, 2006, Pages 686-692

  Bartella, Lia ^a   Morris, Elizabeth A ^a   Dershaw, D David ^a   Liberman, Laura ^a   Thakur, Sunitha B ^a   Moskowitz, Chaya ^a   Guido, Jennifer ^a   Huang, Wei ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BIOPSY TECHNIQUE; BREAST CANCER; CANCER DIAGNOSIS; DIAGNOSTIC VALUE; DISEASE MARKER; HISTOPATHOLOGY; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SIGNAL NOISE RATIO; STATISTICAL SIGNIFICANCE;

ADULT; AGED; BIOPSY; BREAST NEOPLASMS; CHOLINE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTONS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 33744782053     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2393051046     Document Type: Review

References (25)

1. Libermnan L. Breast cancer screening with MRI: what are the data for patients at high risk? N Engl J Med 2004;351:497-500.
2. Robson ME, Offit K. Breast MRI for women with hereditary cancer risk. JAMA 2004;292:1368-1370.
3. Morris EA, Liberman L, Ballon DJ, et al. MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol 2003;181:619-626.
4. Boetes C, Stoutjesdijk M. MR imaging in screening women at increased risk for breast cancer. Magn Reson Imaging Clin N Am 2001;9:357-372.
5. Morris EA. Review of breast MRI: indications and limitations. Semin Roentgenol 2001;36:226-237.
6. Orel SG, Schnall MD. MR imaging of the breast for the defection, diagnosis, and staging of breast cancer. Radiology 2001;220:13-30.
7. Negendank W. Studies of human tumors by MRS: a review. NMR Biomed 1992;5:303-324.
8. Mackinnon WB, Barry PA, Malycha PL, et al. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiology 1997;204:661-666.
9. Aboagye EO, Rhujwalla ZM. Malignant transformation alters membrane choline pbospholipid metabolism of human mammary epithelial cells. Cancer Res 1999;59:80-84.
10. Yeung DK, Yang WT, Tse GM. Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases. Radiology 2002;225:190-197.
11. Yeung DK, Cheung HS, Tse GM. Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy-initial results. Radiology 2001;220:40-46.
12. Kvistad KA, Bakken U, Gribbestad IS, et al. Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy. J Magn Reson Imaging 1999;10:159-164.
13. Cecil KM, Schnall MD, Siegelman ES, Lenkinski RE. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat 2001;68:45-54.
14. Roebuck JR, Cecil KM, Schnall MD, Lenkinski RE. Human breast lesions: characterization with proton MR spectroscopy. Radiology 1998;209:269-275.
15. Gribbestad TS, Singstad TE, Nilsen G, et al. In vivo 1H MRS of normal breast and breast tumors using a dedicated double breast coil. J Magn Reson Imaging 1998;8:1191-1197.
16. Tse GM, Cheung HS, Pang LM, et al. Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors. AJR Am J Roentgenol 2003;181:1267-1272.
17. Bolan PJ, Meisamy S, Baker KH, et al. In vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magn Reson Med 2003;50:1134-1143.
18. Huang W, Fisher PR, Dulaimy K, Tudorica LA, O'Hea B, Button TM. Detection of breast, malignancy: diagnostic MR protocol for improved specificity. Radiology 2004;232:585-591.
19. Jacobs MA, Barker PB, Bottomley PA, Rhujwalla X, Bluemke DA. Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study. J Magn Reson Imaging 2004;19:68-73.
20. Jagannathan NR, Kumar M, Seenu V, et al. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 2001;84:1016-1022.
21. 1H MR spectroscopy-a pilot study at 4 T. Radiology 2004;233:424-431.
22. Liberman L, Morris RA, Dershaw DD, Thornton CM, Van Zee KJ, Tan LK. Fast MRI-guided vacuum-assisted breast biopsy: initial experience. AJR Am J Roentgenol 2003;181:1283-1293.
23. Morris EA, Liberman L, Dershaw DD, et al. Preoperative MR imaging-guided needle localization of breast lesions. AJR Am J Roentgenol 2002;178:1211-1220.
24. American College of Radiology, ACR Breast Imaging Reporting and Data System. Breast Imaging Atlas. Reston, Va: American College of Radiology, 2003.
25. Leisenring W, Alonzo T, Pepe MS. Comparisons of predictive values of binary medical diagnostic tests for paired designs. Biometrics 2000;56:345-351.